Hypovitaminosis D is associated with systemic inflammation and concentric myocardial geometric pattern in hemodialysis patients with low iPTH levels

Nephron - Clinical Practice

Volumn 118, Issue 4, 2011, Pages

  Bucharles, Sérgio ^a,b   Barberato, Silvio H ^a,c   Stinghen, Andrea E ^a   Gruber, Betina ^a   Meister, Henrique ^a   Mehl, Andrieli ^a   Piekala, Luciana ^b   Dambiski, Ana C ^b   Souza, Admar ^c   Olandoski, Márcia ^a   Pecoits Filho, Roberto ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^b Instituto do Rim do Paraná   (Brazil)

^c Hospital Cardiologico Costantini   (Brazil)

Author keywords

Cardiovascular disease; Hemodialysis; Inflammation; Vitamin D

Indexed keywords

C REACTIVE PROTEIN; CALCIFEDIOL; INTERLEUKIN 6;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE SIZE; HEART VENTRICLE WALL; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MYOCARDIUM; PARATHYROID HORMONE; RENAL DIALYSIS; RISK FACTORS; VENTRICULAR REMODELING; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79851513393     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000323664     Document Type: Article

References (39)

1. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(suppl 3):S112-S119. (Pubitemid 28527268)
2. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218. (Pubitemid 39031360)
3. Honda H, Qureshi AR, Heimburger O, Barany P, Wang K, Pecoits-Filho R, et al: Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006; 47: 139-148. (Pubitemid 41828276)
4. Holick MF: Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
5. Del Valle E, Negri AL, Aguirre C, Fradinger E, Zanchetta JR: Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodial Int 2007; 11: 315-321. (Pubitemid 46958585)
6. Mucsi I, Almasi C, Deak G, Marton A, Ambrus C, Berta K, et al: Serum 25(OH)-vitamin D levels and bone metabolism in patients on maintenance hemodialysis. Clin Nephrol 2005; 64: 288-294. (Pubitemid 41448431)
7. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo CA Jr., et al: Activated injectable vitamin D and hemodialysis survival: A historical cohort study. J Am Soc Nephrol 2005; 16: 1115-1125. (Pubitemid 41710323)
8. Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, et al: Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 2006; 70: 1858-1865. (Pubitemid 44684819)
9. Zittermann A: Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 2006; 92: 39-48. (Pubitemid 43831966)
10. Pecoits-Filho R, Barany P, Lindholm B, Heimburger O, Stenvinkel P: Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 2002; 17: 1684-1688. (Pubitemid 35012175)
11. Cohen-Lahav M, Douvdevani A, Chaimovitz C, Shany S: The anti-inflammatory activity of 1,25-dihydroxyvitamin D 3 in macrophages. J Steroid Biochem Mol Biol 2007; 103: 558-562.
12. Panichi V, De Pietro S, Andreini B, Bianchi AM, Migliori M, Taccola D, et al: Calcitriol modulates in vivo and in vitro cytokine production: A role for intracellular calcium. Kidney Int 1998; 54: 1463-1469. (Pubitemid 28502888)
13. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, et al: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47: 186-192.
14. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP: 1,25-Dihydroxyvitamin D 3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110: 229-238. (Pubitemid 34787360)
15. Achinger SG, Ayus JC: The role of vitamin D in left ventricular hypertrophy and cardiac function. Kidney Int Suppl 2005; 95:S37-S42. (Pubitemid 43361555)
16. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42(suppl 3):S1-S201.
17. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009; 113:S1-S130.
18. Hollis BW: Editorial: The determination of circulating 25-hydroxyvitamin D: No easy task. J Clin Endocrinol Metab 2004; 89: 3149-3151. (Pubitemid 38951876)
19. Zerwekh JE: Blood biomarkers of vitamin D status. Am J Clin Nutr 2008; 87: 1087S-1091S. (Pubitemid 351549268)
20. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre PE: Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 1996; 49: 1428-1434. (Pubitemid 26166417)
21. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-618. (Pubitemid 8066109)
22. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, et al: Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992; 20: 1251-1260.
23. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA: Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002; 15: 167-184.
24. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al: Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463. (Pubitemid 41821197)
25. Sohn DW, Song JM, Zo JH, Chai IH, Kim HS, Chun HG, et al: Mitral annulus velocity in the evaluation of left ventricular diastolic function in atrial fibrillation. J Am Soc Echocardiogr 1999; 12: 927-931.
26. Pritchett AM, Jacobsen SJ, Mahoney DW, Rodeheffer RJ, Bailey KR, Redfield MM: Left atrial volume as an index of left atrial size: A population-based study. J Am Coll Cardiol 200319; 41: 1036-1043. (Pubitemid 36315550)
27. Barberato SH, Pecoits Filho R: Prognostic value of left atrial volume index in hemodialysis patients. Arq Bras Cardiol 2007; 88: 643-650.
28. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF: Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52: 1949-1956.
29. Andress DL: Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation. Kidney Int 2006; 69: 33-43. (Pubitemid 43117736)
30. LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q, et al: Prevalence of calcidiol deficiency in CKD: A cross-sectional study across latitudes in the United States. Am J Kidney Dis 2005; 45: 1026-1033. (Pubitemid 40806515)
31. Matias PJ, Ferreira C, Jorge C, Borges M, Aires I, Amaral T, et al: 25-Hydroxyvitamin D 3 , arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant 2009; 24: 611-618.
32. Takahashi K, Horiuchi H, Ohta T, Komoriya K, Ohmori H, Kamimura T: 1 alpha,25-dihydroxyvitamin D3 suppresses interleukin-1beta-induced interleukin-8 production in human whole blood: An involvement of erythrocytes in the inhibition. Immunopharmacol Immunotoxicol 2002; 24: 1-15. (Pubitemid 34496732)
33. Huting J, Alpert MA: Course of left ventricular diastolic dysfunction in end-stage renal disease on long-term continuous ambulatory peritoneal dialysis. Clin Nephrol 1993; 39: 81-87. (Pubitemid 23077805)
34. Covic A, Goldsmith DJ, Georgescu G, Venning MC, Ackrill P: Echocardiographic findings in long-term, long-hour hemodialysis patients. Clin Nephrol 1996; 45: 104-110. (Pubitemid 26056958)
35. London GM: Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant 2002; 17(suppl 1):29-36. (Pubitemid 34157116)
36. Valdivielso JM, Ayus JC: Role of vitamin D receptor activators on cardiovascular risk. Kidney Int Suppl 2008; 111:S44-S49.
37. Foley RN, Curtis BM, Randell EW, Parfrey PS: Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease. Clin J Am Soc Nephrol 2010; 5: 805-813.
38. Lemmila S, Saha H, Virtanen V, Ala-Houhala I, Pasternack A: Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis. Am J Nephrol 1998; 18: 404-410. (Pubitemid 28442103)
39. Matias PJ, Jorge C, Ferreira C, Borges M, Aires I, Amaral T, et al: Cholecalciferol supplementation in hemodialysis patients: Effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol 2010; 5: 905-911.